Experience NOCITA®

(bupivacaine liposome injectable suspension)

Now your veterinarian can help extend pain relief after your dog’s cranial cruciate ligament surgery.

All surgical procedures result in some degree of tissue trauma and pain. As pain can delay healing and return to function, veterinarians strive to minimize your dog’s discomfort following surgery.

Now NOCITA® is here to help. As an extended-release medication, it can help veterinarians better manage post-operative pain in dogs undergoing cranial cruciate ligament surgery.

Nocita post-operative pain relief

Long-acting pain relief

The use of bupivacaine (a well-known local anesthetic) in a long-acting injectable formula has been proven to extend the duration of human post-operative analgesia from up to seven hours1 to as long as 72 hours. Now similar results have been demonstrated in dogs with the use of NOCITA®.

Ask your veterinarian

NOCITA® has been thoroughly tested in clinical studies. Ask your veterinarian for more details on how it could extend post-operative pain relief for your dog undergoing cranial cruciate ligament surgery.

  • 1Marcaine [package insert]. Lake Forest, IL: Hospira, Inc; 2014.

IMPORTANT SAFETY INFORMATION: NOCITA® (bupivacaine liposome injectable suspension) is for use in dogs only. Do not use in dogs younger than 5 months of age, dogs used for breeding, or in pregnant or lactating dogs. Do not administer by intravenous or intra-arterial injection. Adverse reactions in dogs may include discharge from incision, incisional inflammation and vomiting. Avoid concurrent use with bupivacaine HCl, lidocaine or other amide local anesthetics. Please see the full Prescribing Information or contact your veterinarian for more detail.

Are you a veterinary professional?

Learn more about how long-acting NOCITA® could provide the post-surgical pain relief for your patients undergoing cranial cruciate ligament surgery.


Other therapeutics from Aratana






ENTYCE® (capromorelin oral solution)
provides appetite stimulation.

Inappetence in dogs is a serious problem. Recently-FDA-approved ENTYCE® provides safe, effective appetite stimulation.


IMPORTANT SAFETY INFORMATION: ENTYCE® (capromorelin oral solution) is for use in dogs only. Do not use in breeding, pregnant or lactating dogs. Use with caution in dogs with hepatic dysfunction or renal insufficiency. Adverse reactions in dogs may include diarrhea, vomiting, polydipsia, and hypersalivation. Should not be used in dogs that have a hypersensitivity to capromorelin. Please see the full Prescribing Information for more detail.